CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank58
3Y CAGR+22.6%
5Y CAGR-34.4%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+22.6%/yr
Annual compound
5Y CAGR
-34.4%/yr
Recent acceleration
Percentile
P58
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 12.40% |
| 2024 | -52.16% |
| 2023 | 49.46% |
| 2022 | 6.72% |
| 2021 | -4189.49% |
| 2020 | 102.05% |
| 2019 | -81.54% |
| 2018 | -146.98% |
| 2017 | 4111.74% |
| 2016 | 85.49% |